JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB62075

Anti-BRCC36 antibody

Be the first to review this product! Submit a review

|

(4 Publications)

Rabbit Polyclonal BRCC36 antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 4 publications. Immunogen corresponding to Synthetic Peptide within Human BRCC3.

View Alternative Names

BRCC36, C6.1A, CXorf53, BRCC3, Lys-63-specific deubiquitinase BRCC36, BRCA1-A complex subunit BRCC36, BRCA1/BRCA2-containing complex subunit 3, BRCA1/BRCA2-containing complex subunit 36, BRISC complex subunit BRCC36

3 Images
Immunocytochemistry/ Immunofluorescence - Anti-BRCC36 antibody (AB62075)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-BRCC36 antibody (AB62075)

Immunofluorescence of BRCC36 in Human Brain cells using ab62075 at 20 ug/ml.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BRCC36 antibody (AB62075)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BRCC36 antibody (AB62075)

ab62075 at 2.5 μg/ml staining BRCC36 in human brain tissue section by Immunohistochemistry (Formalin/ PFA fixed paraffin-embedded sections).

Western blot - Anti-BRCC36 antibody (AB62075)
  • WB

Unknown

Western blot - Anti-BRCC36 antibody (AB62075)

Lane 1:

Western blot - Anti-BRCC36 antibody (ab62075) at 0.5 µg/mL

Lane 2:

Western blot - Anti-BRCC36 antibody (ab62075) at 1 µg/mL

Lane 3:

Western blot - Anti-BRCC36 antibody (ab62075) at 2 µg/mL

All lanes:

MCF7 cell lysate at 10 µg

Secondary

All lanes:

anti-rabbit IgG

Predicted band size: 36 kDa

Observed band size: 36 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, ICC/IF, IHC-P

applications

Immunogen

Synthetic Peptide within Human BRCC3. The exact immunogen used to generate this antibody is proprietary information.

P46736

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.5-1 µg/mL", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "2.5 µg/mL", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "20 µg/mL", "ICCIF-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.2 Preservative: 0.02% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Metalloprotease that specifically cleaves 'Lys-63'-linked polyubiquitin chains (PubMed : 19214193, PubMed : 20656690, PubMed : 24075985, PubMed : 26344097). Does not have activity toward 'Lys-48'-linked polyubiquitin chains (PubMed : 19214193, PubMed : 20656690, PubMed : 24075985, PubMed : 26344097). Component of the BRCA1-A complex, a complex that specifically recognizes 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage at double-strand breaks (DSBs) (PubMed : 14636569, PubMed : 16707425, PubMed : 17525341, PubMed : 19202061, PubMed : 19261746, PubMed : 19261748, PubMed : 19261749). In the BRCA1-A complex, it specifically removes 'Lys-63'-linked ubiquitin on histones H2A and H2AX, antagonizing the RNF8-dependent ubiquitination at double-strand breaks (DSBs) (PubMed : 20656690). Catalytic subunit of the BRISC complex, a multiprotein complex that specifically cleaves 'Lys-63'-linked ubiquitin in various substrates (PubMed : 20656690, PubMed : 24075985, PubMed : 26195665, PubMed : 26344097). Mediates the specific 'Lys-63'-specific deubiquitination associated with the COP9 signalosome complex (CSN), via the interaction of the BRISC complex with the CSN complex (PubMed : 19214193). The BRISC complex is required for normal mitotic spindle assembly and microtubule attachment to kinetochores via its role in deubiquitinating NUMA1 (PubMed : 26195665). Plays a role in interferon signaling via its role in the deubiquitination of the interferon receptor IFNAR1; deubiquitination increases IFNAR1 activity by enhancing its stability and cell surface expression (PubMed : 24075985, PubMed : 26344097). Acts as a regulator of the NLRP3 inflammasome by mediating deubiquitination of NLRP3, leading to NLRP3 inflammasome assembly (By similarity). Down-regulates the response to bacterial lipopolysaccharide (LPS) via its role in IFNAR1 deubiquitination (PubMed : 24075985). Deubiquitinates HDAC1 and PWWP2B leading to their stabilization (By similarity).
See full target information BRCC3

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

Acta biochimica et biophysica Sinica 56:564-575 PubMed38449391

2024

The deubiquitinase BRCC3 increases the stability of ZEB1 and promotes the proliferation and metastasis of triple-negative breast cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Qidi Huang,Shurong Zheng,Huayan Gu,Zhi Yang,Yiqiao Lu,Xia Yu,Guilong Guo

Glia 67:1775-1792 PubMed31184779

2019

BRCA1/BRCA2-containing complex subunit 3 controls oligodendrocyte differentiation by dynamically regulating lysine 63-linked ubiquitination.

Applications

Unspecified application

Species

Unspecified reactive species

Chih-Yen Wang,Benjamin Deneen,Shun-Fen Tzeng

Molecular medicine reports 18:4886-4894 PubMed30272359

2018

Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro.

Applications

Unspecified application

Species

Unspecified reactive species

Feifang Zhang,Qun Zhou

Nature communications 9:537 PubMed29416040

2018

BRE/BRCC45 regulates CDC25A stability by recruiting USP7 in response to DNA damage.

Applications

Unspecified application

Species

Unspecified reactive species

Kajal Biswas,Subha Philip,Aditya Yadav,Betty K Martin,Sandra Burkett,Vaibhav Singh,Anav Babbar,Susan Lynn North,Suhwan Chang,Shyam K Sharan
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com